Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of April 2020, specifically dated April 21, 2020. The document reports on a corporate governance event regarding a Special Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes are reported. The primary event is the adjournment of the Special Meeting of Shareholders originally scheduled for April 21, 2020, due to a lack of quorum.
Outlook and Management Commentary
Management has reconvened the Special Meeting of Shareholders for Tuesday, April 28, 2020, at 4:00 p.m. (Israel time). The meeting will be held at the Company's offices located at 10 Bareket Street, Petach Tikva, Israel. No specific business outlook, risks, or contingencies are detailed in this text.
Key Facts for Investors
- The Special Meeting of Shareholders scheduled for April 21, 2020, was adjourned due to a lack of quorum.
- The meeting has been rescheduled for April 28, 2020, at the same time and location.
- This filing contains no financial performance data or updated guidance.